Formal UK Medical Devices Legislation Expected In Spring

The Queen’s speech last month signaled new legislation for medical devices after the UK leaves the umbrella of EU legislation, following the December election result. The bill is expected to enter its second reading in March 2020.

Parliament

The Queen’s speech of 19 December, and background information published on 20 December, came just a week after the election result that was effectively the pro-Brexit vindication that UK prime minister Boris Johnson saw as long-overdue after the June 2016 referendum.

It effectively brought to an end the wrangling over the merits of UK membership of the EU. (Also see "

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

Lack Of Taxpayer Value Leads UK MHRA To Shutter RegulatoryConnect Transparency Program

 

The UK Medicines and Healthcare products Regulatory Agency said its RegulatoryConnect program “no longer offers value for money for UK taxpayers” and will be closed just 19 months after its April 2024 launch.

Prosthetics: Firms Like Unhindr And Esper Shape Market On the Cusp of Great Change

 

The prosthetics market is evolving due to an increase in amputees from war and disease. Unhindr has developed a novel prostetic liner that can reduce the risk of further injury, while Esper is crafting advanced hand implants for Ukraine's front-line soldiers.

UK MHRA Deepens AI Regulatory Expertise As Airlock Moves Into Phase 2

 
• By 

The first-of-its-kind sandbox for insights on how to regulate artificial intelligence in healthcare has accepted seven more AI innovators onto its learning program.

UK Medtechs On A Journey To MARRS Find Welcome Regulatory Funding Support

 
• By 

Market and regulatory support for 117 new and 91 existing devices under 2024-25 technology funding program run by UK innovation agency CPI benefits 141 SMEs – but demand for regulatory support outstrips supply.

More from Europe

Notified Bodies Have Availability Now - But The Situation Won’t Last

 

Medtech companies should not look at the current period as a regulatory hiatus, but as an opportunity to avoid a crisis two to three years down the line.

TEAM-NB Spells Out What Needs To Happen When Transferring Legacy Devices

 

The association’s recent position paper highlights how complex the transfer process is but explains to manufacturers and notified bodies how to meet the requirements.

Lack Of Taxpayer Value Leads UK MHRA To Shutter RegulatoryConnect Transparency Program

 

The UK Medicines and Healthcare products Regulatory Agency said its RegulatoryConnect program “no longer offers value for money for UK taxpayers” and will be closed just 19 months after its April 2024 launch.